pitolisant 4.45 MG Oral Tablet

RxCUI
2197884
RxNorm name
pitolisant 4.45 MG Oral Tablet
Display name
pitolisant 4.45 MG Oral Tablet
Full name
pitolisant 4.45 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WakixPITOLISANT HYDROCHLORIDEHarmony Biosciences, LLC8daa5562-824e-476c-9652-26ceef3d4b0e2026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 2197884

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8daa5562-824e-476c-9652-26ceef3d4b0epitolisant 4.45 MG Oral Tablet [PSN] · pitolisant 4.45 MG Oral Tablet [SCD] · pitolisant 4.45 MG (as pitolisant HCl 5 MG) Oral Tablet [SY]318These highlights do not include all the information needed to use WAKIX ® safely and effectively. See full prescribing information for WAKIX. WAKIX ® (pitolisant) tablets, for oral use Initial U.S. Approval: 201920260213